Literature DB >> 16595069

Management of extravasation of oxaliplatin.

Mário L de Lemos1, Susan Walisser.   

Abstract

Oxaliplatin extravasation has been associated with local pain and inflammation which may be severe and lead to complications including necrosis. Recent case reports suggest that oxaliplatin may be better classified as an irritant when extravasated. The optimal management of oxaliplatin extravasation however remains uncertain. Cold compress may cause local vasoconstriction and reduce cellular injury. However, it may potentially precipitate or worsen peripheral neuropathy. Warm compress may increase drug removal by local vasodilation and avoid peripheral neuropathy. However, it may potentially increase cellular uptake and hence injury. Further research into this area is needed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16595069     DOI: 10.1191/1078155205jp165oa

Source DB:  PubMed          Journal:  J Oncol Pharm Pract        ISSN: 1078-1552            Impact factor:   1.809


  4 in total

1.  A midline for oxaliplatin infusion: the myth of safety devices.

Authors:  Ben Masters; Tamas Hickish; Esther Uña Cidon
Journal:  BMJ Case Rep       Date:  2014-06-05

2.  Cervical dissecting extravasation of oxaliplatin: A case report.

Authors:  Jorge Hernando; Judit Riera-Arnau; Maria Roca; Alejandro Garcia; Jaume Capdevila
Journal:  Mol Clin Oncol       Date:  2022-01-12

3.  Extravasation of oxaliplatin: an infrequent and irritant toxicity.

Authors:  C Pericay; A López; J R Soler; T Bonfill; E Dotor; E Saigí
Journal:  Clin Transl Oncol       Date:  2009-02       Impact factor: 3.405

Review 4.  The Impact of Peripheral Cooling on Chemotherapy-Induced Peripheral Neuropathy: An Integrative Review.

Authors:  Bethany G Sphar; Christi Bowe; Joyce E Dains
Journal:  J Adv Pract Oncol       Date:  2020-11-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.